We demonstrate that targeting HDAC10 sensitizes neuroblastoma cells to doxorubicin by inhibiting drug efflux via lysosomal exocytosis and enhancing DNA double-strand breaks, thereby promoting tumor cell death in chemotherapy resistant neuroblastoma models. This evidence concerns the gene HDAC10 and neuroblastoma.